]>
IRCT201203108567N1 IRCT 2012-03-10 Vice chancellor for research, Shahid Beheshti University of Medical Sciences Effects of transplantation (non-cultured autologous melanocytes) in stable vitiligo plaques. Effects of transplantation (non-cultured autologous melanocytes) bulge region , dermal papilla and outer root sheet in stable vitiligo plaques. 2012-01-01 anticipated 10 Complete https://irct.ir/trial/9061 interventional Randomization: Randomized, Blinding: Double blinded, Placebo: Used, Assignment: Parallel, Purpose: Treatment. N/A Vitiligo. Intervention 1: Intervention group: initially a small areas of the head selected by lidocaine with epinephrine anesthetic is then using a punch mm5 in the area occuipital removed and the bulge and outer root sheet and dermal papilla may be extracted by suspension of the procurement 3 is injected into the area.Scheme used in this study, a block design capacity is 3 for each block. The patient in this study, is considered a block and a third treatment is performed on each patient. Block designs, random allocation of treatments in each block must be done. Plaque in the first two of which will be created later dermal abration with needle are traumatized. a - The main area where melanocytes Dermal papilla and outer Root sheet plus the Bulge area into the area. Intervention 2: C - with the other, as seen in the control and the treatment will not be around either. Intervention 3: B - with the other, just insert a needle to create traumaand respond to trauma.
public Dr. Shakoei
Shohada hospital shahrdari St. Tajrish Sq.
Tehran Iran (Islamic Republic of) 198993414 +98 21 2274 1507 dr.shakoei@gmail.com Dermatology Research Center scientific Dr.Toosi
Shohada hospital shahrdari St. Tajrish Sq.
Tehran Iran (Islamic Republic of) 198993414 +98 21 2274 1507 src@tums.ac.ir Dermatology Research Center Iran (Islamic Republic of) Criteria for inclusion: 1) At least 4 years have passed since the onset of their disease. 2) at least 6 months of stable disease and no new leions. 3) The patient's lesions are bilateral.symetric 4) There is not an appropriate response to other therapies. 5) There is no history of disease. Such as hypothyroidism, hyperthyroidism, diabetes, asthma, atopic dermatitis, rhinitis, psoriasis, ulceritive colitis, lupus, alopecia areata, anemia Pernisious ... 6) not currently being treated with other methods. Exclusion criteria: 1) pregnant women. 2) The incidence of these diseases 3) parts of the body that are routinely exposed to light. 4) patients who once responded to NBUVB return is after the break. 5) kelloid 20 years 55 years Both L80 Vitiligo Treatment - Surgery N/A Treatment - Surgery Intervention group: initially a small areas of the head selected by lidocaine with epinephrine anesthetic is then using a punch mm5 in the area occuipital removed and the bulge and outer root sheet and dermal papilla may be extracted by suspension of the procurement 3 is injected into the area.Scheme used in this study, a block design capacity is 3 for each block. The patient in this study, is considered a block and a third treatment is performed on each patient. Block designs, random allocation of treatments in each block must be done. Plaque in the first two of which will be created later dermal abration with needle are traumatized. a - The main area where melanocytes Dermal papilla and outer Root sheet plus the Bulge area into the area. C - with the other, as seen in the control and the treatment will not be around either. B - with the other, just insert a needle to create traumaand respond to trauma Repigmentation. Timepoint: One month. Method of measurement: Size and photo. Side effect. Timepoint: During study. Method of measurement: Observation. Vice chancellor for research, Shahid Beheshti University of Medical Sciences Approved 2011-02-27 Skin Research Center Ethics Committee Shohada hospital, Shahrdari St.,Tajrish Sq. Tehran Iran (Islamic Republic of)